Outcomes with trastuzumab deruxtecan by biomarker status, line of treatment and prior receipt of sacituzumab govitecan in a large real-world database of patients with metastatic breast cancer. - Tarantino P; Lee D; Foldi J; Soulos PR; Gross CP; Grinda T; Winer EP; Lin NU; Krop IE; Tolaney SM; Lustberg M; Sammons S (ESMO open, 2025)